| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $0.3374 (Beat by $0.0174) |
| EPS GAAP Actual | $0.3374 (Beat by $0.0174) |
| Revenue Actual | $1.02611B |
| Revenue Surprise | Beat by $1026.11M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 1.61 | 40.27 | 1.57198 | 1.63855 | 1 |
| Dec 2028 | 0 | INF | 0 | 0 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.34 | 0.34 | 1.02611B | 259.85% | 1026.11M |
| FQ2 2025 (Jun 2025) | 0.29 | 0.29 | 0.999527B | 10.77% | 999.53M |
| FQ1 2025 (Mar 2025) | 0.22 | 0.22 | 0.822504B | 9.02% | 822.5M |
| FQ4 2024 (Dec 2024) | 0.22 | 0.22 | 0.832169B | 9.38% | 832.17M |
| FQ3 2024 (Sep 2024) | 0.28 | 0.28 | -1.64027B | 151.24% | -1640.27M |
| FQ2 2024 (Jun 2024) | 0.27 | 0.27 | 0.89192B | 7.98% | 891.92M |
| FQ1 2024 (Mar 2024) | 0.19 | 0.19 | 0.748349B | 12.07% | 748.35M |
| FQ4 2023 (Dec 2023) | 0.22 | 0.22 | 0.754086B | 12.29% | 754.09M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.35 | -- | 0.34114 | 0.35497 | 2 |
| FQ3 2027 (Sep 2027) | 0.43 | -- | 0.41911 | 0.43611 | 2 |
| FQ2 2027 (Jun 2027) | 0.38 | -- | 0.37038 | 0.3854 | 2 |
| FQ1 2027 (Mar 2027) | 0.28 | -- | 0.27291 | 0.28398 | 2 |
| FQ4 2026 (Oct 2026) | 0.36365 | -- | 0.35406 | 0.37064 | 3 |
| FQ3 2026 (Jul 2026) | 0.32345 | -5.12 | 0.31492 | 0.32967 | 3 |
| FQ2 2026 (Jun 2026) | 0.33831 | 14.28 | 0.32974 | 0.34312 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.11B | -- | 1.09B | 1.12B | 2 |
| FQ3 2027 (Sep 2027) | 1.22B | -- | 1.2B | 1.24B | 2 |
| FQ2 2027 (Jun 2027) | 1.19B | -- | 1.17B | 1.21B | 2 |
| FQ1 2027 (Mar 2027) | 1B | -- | 0.98B | 1.01B | 2 |
| FQ4 2026 (Oct 2026) | 1.04B | -- | 1.02B | 1.05B | 2 |
| FQ3 2026 (Jul 2026) | 1.02B | -0.76 | 1B | 1.03B | 2 |
| FQ2 2026 (Jun 2026) | 1.09B | 8.21 | 1.07B | 1.1B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.34 | 0.34 | 100% | |
| FQ2 2025 (Jun 2025) | 0.29 | 0.29 | 100% | |
| FQ1 2025 (Mar 2025) | 0.22 | 0.22 | 100% | |
| FQ4 2024 (Dec 2024) | 0.22 | 0.22 | 100% | |
| FQ3 2024 (Sep 2024) | 0.28 | 0.28 | 100% | |
| FQ2 2024 (Jun 2024) | 0.27 | 0.27 | 100% | |
| FQ1 2024 (Mar 2024) | 0.19 | 0.19 | 100% | |
| FQ4 2023 (Dec 2023) | 0.22 | 0.22 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $1.03B | $1026.11M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $1B | $999.53M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.82B | $822.5M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.83B | $832.17M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $-1.64B | $-1640.27M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.89B | $891.92M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.75B | $748.35M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.75B | $754.09M | 100% |